​Medicines agencies around the world are in close dialogue with research scientists and pharmaceutical companies that are developing vaccines against covid-19. This also applies to the European Medicines Agency (EMA), to which Norway is affiliated. The EMA has set up a Pandemic Task Force (COVID-ETF), which is responsible for the rapid coordination of resources and the provision of support to various research projects being carried out within the EU. The EMA is also working closely with the World Health Organization (WHO).

 

The approval process for covid-19 vaccines

The various vaccine technologies

Reported suspected adverse reactions of covid-19 vaccines

Oppdatert: 16.07.2021

Publisert: 14.07.2020

​Fant du det du lette etter?